may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful
.
.
.
.
.
.
the total amount paid out in critical illness claims was £75.19m, with cancer accounting for 74 per cent of claims from women, mainly breast cancer, alongside 51 per cent from men.
.
.